Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01677741
Title A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child
Covered Countries USA | ITA | ISR | GBR | FRA | ESP | DNK | DEU | CAN | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site Phoenix Arizona 85016-7710 United States Details
Novartis Investigative Site Orange California 92868 United States Details
Novartis Investigative Site Baltimore Maryland 21287 United States Details
Novartis Investigative Site Boston Massachusetts 02215 United States Details
Novartis Investigative Site New York New York 10065 United States Details
Novartis Investigative Site Cincinnati Ohio 45229 United States Details
Novartis Investigative Site Memphis Tennessee 38105-3678 United States Details
Novartis Investigative Site Seattle Washington 98105 United States Details
Novartis Investigative Site Parkville Victoria 3052 Australia Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Marseille Cedex 5 13385 France Details
Novartis Investigative Site Paris cedex 05 75248 France Details
Novartis Investigative Site Paris cedex 12 75571 France Details
Novartis Investigative Site Toulouse cedex 9 31059 France Details
Novartis Investigative Site Villejuif Cedex 94805 France Details
Novartis Investigative Site Heidelberg Baden-Wuerttemberg 69120 Germany Details
Novartis Investigative Site Regensburg Bayern 93053 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Jerusalem 91120 Israel Details
Novartis Investigative Site Ramat-Gan 52621 Israel Details
Novartis Investigative Site Milan 20133 Italy Details
Novartis Investigative Site Esplugues De Llobregat. Barcelona 08950 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
Novartis Investigative Site London WC1N 3JH United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field